Elutia (ELUT) EPS (Basic) (2019 - 2026)

Elutia (ELUT) posted EPS (Basic) of $0.01 for Q1 2026, down 97.66% sequentially from $0.42 in Q4 2025, and up 109.7% YoY from $0.0 in Q1 2025.

Elutia (ELUT) EPS (Basic) (2019 - 2026) Analysis & Trends

Elutia has reported EPS (Basic) for 8 years, with the latest figure at $0.01 in Q1 2026.

Quarterly EPS (Basic) rose 109.7% year-over-year to $0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.1 (down 71.27% YoY) and the FY2025 annual result came in at $0.0, up 169.45% from the prior year.
EPS (Basic) eased to $0.01 in Q1 2026 per ELUT's latest filing, from $0.42 in the prior quarter.
Over five years, EPS (Basic) peaked at $1.54 in Q4 2024 and troughed at -$1.13 in Q2 2024.
A 5-year average of -$0.3 and a median of -$0.48 in 2023 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2024 and 2025: EPS (Basic) surged 317.0% in 2024, then sank 377.84% in 2025.
Over 5 years, EPS (Basic) stood at -$0.39 in 2022, then plunged by 80.72% to -$0.71 in 2023, then soared by 317.0% to $1.54 in 2024, then tumbled by 72.66% to $0.42 in 2025, then slumped by 97.66% to $0.01 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered $0.01, $0.42, and -$0.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.53
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	3.33
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.98
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.42
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.65
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.06
10	Elutia	40.25 Mn	20.35 Mn	1.45 Mn	-0.17

Download Data